Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Hisamitsu Pharmaceutical Co ( (JP:4530) ) has issued an update.
Hisamitsu Pharmaceutical Co. reported a significant increase in its financial performance for the fiscal year ended February 28, 2025, with net sales rising by 10.1% and profit attributable to owners of the parent increasing by 55.8%. The company also announced a commemorative dividend in celebration of the anniversaries of its flagship products, indicating a strong market position and shareholder value appreciation.
More about Hisamitsu Pharmaceutical Co
Hisamitsu Pharmaceutical Co., Inc. is a company listed on the Tokyo, Nagoya, and Fukuoka stock exchanges, known for its pharmaceutical products, including the well-known SALONPAS® and MOHRUS® Tapes. The company focuses on developing and marketing products that provide pain relief and other health benefits.
YTD Price Performance: 3.33%
Average Trading Volume: 100
Technical Sentiment Signal: Strong Buy
Current Market Cap: $2.06B
See more data about 4530 stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue